[1]
|
Stinton, L.M. and Shaffer, E.A. (2012) Epidemiology of Gallbladder Disease: Cholelithiasis and Cancer. Gut Liver, 6, 172-187. https://doi.org/10.5009/gnl.2012.6.2.172
|
[2]
|
Sakorafas, G.H., Milingos, D. and Peros, G. (2007) Asymptomatic Cholelithiasis: Is Cholecystectomy Really Needed? A Critical Reappraisal 15 Years after the Introduction of Laparoscopic Cholecystectomy. Digestive Diseases and Sciences, 52, 1313-1325. https://doi.org/10.1007/s10620-006-9107-3
|
[3]
|
Shrikhande, S.V., Barreto, S.G., Singh, S., Udwadia, T.E. and Agarwal, A.K. (2010) Cholelithiasis in Gallbladder Cancer: Coincidence, Cofactor, or Cause! European Journal of Sur-gical Oncology, 36, 514-519.
https://doi.org/10.1016/j.ejso.2010.05.002
|
[4]
|
Randi, G., Franceschi, S. and La Vecchia, C. (2006) Gallbladder Cancer Worldwide: Geographical Distribution and Risk Factors. International Journal of Cancer, 118, 1591-1602. https://doi.org/10.1002/ijc.21683
|
[5]
|
Song, S.T., Shi, J., Wang, X.H., et al. (2020) Prevalence and Risk Factors for Gallstone Disease: A Population-Based Cross-Sectional Study. Journal of Digestive Diseases, 21, 237-245. https://doi.org/10.1111/1751-2980.12857
|
[6]
|
Shaffer, E.A. (2005) Epidemiology and Risk Factors for Gallstone Disease: Has the Paradigm Changed in the 21st Century? Current Gastroenterology Reports, 7, 132-140. https://doi.org/10.1007/s11894-005-0051-8
|
[7]
|
Swarne, E., Srikanth, M.S., Shreyas, A., et al. (2021) Recent Ad-vances, Novel Targets and Treatments for Cholelithiasis; a Narrative Review. European Journal of Pharmacology, 908, Article ID: 174376.
https://doi.org/10.1016/j.ejphar.2021.174376
|
[8]
|
Everhart, J.E., Yeh, F., Lee, E.T., et al. (2002) Prevalence of Gallbladder Disease in American Indian Populations: Findings from the Strong Heart Study. Hepatology, 35, 1507-1512. https://doi.org/10.1053/jhep.2002.33336
|
[9]
|
Grimaldi, C.H., Nelson, R.G., Pettitt, D.J., et al. (1993) Increased Mortality with Gallstone Disease: Results of a 20-Year Population-Based Survey in Pima Indians. Annals of Internal Medicine, 118, 185-190.
https://doi.org/10.7326/0003-4819-118-3-199302010-00005
|
[10]
|
Biss, K., Ho, K.J., Mikkelson, B., Lewis, L. and Taylor, C.B. (1971) Some Unique Biologic Characteristics of the Masai of East Africa. New England Journal of Medi-cine, 284, 694-699. https://doi.org/10.1056/NEJM197104012841304
|
[11]
|
Everhart, J.E. (2001) Gallstones and Ethnicity in the Americas. Journal of the Association for Academic Minority Physicians, 12, 137-143.
|
[12]
|
Aerts, R. and Penninckx, F. (2003) The Burden of Gallstone Disease in Europe. Alimentary Pharmacology & Therapeutics, 18, 49-53. https://doi.org/10.1046/j.0953-0673.2003.01721.x
|
[13]
|
Shaffer, E.A. (2006) Gallstone Disease: Epidemiol-ogy of Gallbladder Stone Disease. Best Practice & Research Clinical Gastroenterology, 20, 981-996. https://doi.org/10.1016/j.bpg.2006.05.004
|
[14]
|
Figueiredo, J.C., Haiman, C., Porcel, J., et al. (2017) Sex and Eth-nic/Racial-Specific Risk Factors for Gallbladder Disease. BMC Gastroenterology, 17, Article No. 153. https://doi.org/10.1186/s12876-017-0678-6
|
[15]
|
Chang, C.-M., Chiu, T.H.T., Chang, C.-C., Lin, M.-N. and Lin, C.-L. (2019) Plant-Based Diet, Cholesterol, and Risk of Gallstone Disease: A Prospective Study. Nutrients, 11, Article No. 335. https://doi.org/10.3390/nu11020335
|
[16]
|
Zhang, J.-W., Xiong, J.-P., Xu, W.-Y., et al. (2019) Fruits and Vegetables Consumption and the Risk of Gallstone Diasease: A Systematic Review and Meta-Analysis. Medicine, 98, e16404.
https://doi.org/10.1097/MD.0000000000016404
|
[17]
|
Hemminki, K., Hemminki, O., Försti, A., et al. (2017) Fa-milial Risks for Gallstones in the Population of Sweden. BMJ Open Gastroenterology, 4, e000188. https://doi.org/10.1136/bmjgast-2017-000188
|
[18]
|
Ansari-Moghaddam, A., Khorram, A., Miri-Bonjar, M., Mo-hammadi, M. and Ansari, H. (2015) The Prevalence and Risk Factors of Gallstone among Adults in South-East of Iran: A Population-Based Study. Global Journal of Health Science, 8, 60-67. https://doi.org/10.5539/gjhs.v8n4p60
|
[19]
|
Pak, M. and Lindseth, G. (2016) Risk Factors for Cholelithiasis. Gas-troenterology Nursing, 39, 297-309.
https://doi.org/10.1097/SGA.0000000000000235
|
[20]
|
Ko, C.W., Beresford, S.A.A., Schulte, S.J., Matsumoto, A.M. and Lee, S.P. (2005) Incidence, Natural History, and Risk Factors for Biliary Sludge and Stones during Pregnancy. Hepatology, 41, 359-365.
https://doi.org/10.1002/hep.20534
|
[21]
|
Kolbeinsson, H.M., Hardardottir, H., Birgisson, G. and Möller, P.H. (2016) [Gallstone Disease during Pregnancy at Landspitali University Hospital 1990-2010]. Læknablaðið, 102, 538-542. (In Icelandic)
https://doi.org/10.17992/lbl.2016.12.110
|
[22]
|
Einarsson, K., Nilsell, K., Leijd, B. and Angelin, B. (1985) Influence of Age on Secretion of Cholesterol and Synthesis of Bile Acids by the Liver. New England Journal of Medicine, 313, 277-282.
https://doi.org/10.1056/NEJM198508013130501
|
[23]
|
Völzke, H., Baumeister, S.E., Alte, D., et al. (2005) Inde-pendent Risk Factors for Gallstone Formation in a Region with High Cholelithiasis Prevalence. Digestion, 71, 97-105. https://doi.org/10.1159/000084525
|
[24]
|
Kimura, Y., Takada, T., Kawarada, Y., et al. (2007) Definitions, Patho-physiology, and Epidemiology of Acute Cholangitis and Cholecystitis: Tokyo Guidelines. Journal of Hepa-to-Biliary-Pancreatic Surgery, 14, 15-26.
https://doi.org/10.1007/s00534-006-1152-y
|
[25]
|
Klass, D.M., Bührmann, K., Sauter, G., et al. (2006) Biliary Li-pids, Cholesterol and Bile Synthesis: Different Adaptive Mechanisms to Dietary Cholesterol in Lean and Obese Subjects. Alimentary Pharmacology & Therapeutics, 23, 895-905.
https://doi.org/10.1111/j.1365-2036.2006.02836.x
|
[26]
|
Lin, I.-C., Yang, Y.-W., Wu, M.-F., et al. (2014) The As-sociation of Metabolic Syndrome and Its Factors with Gallstone Disease. BMC Primary Care, 15, Article No. 138. https://doi.org/10.1186/1471-2296-15-138
|
[27]
|
Cruz-Monserrate, Z., Conwell, D.L. and Krishna, S.G. (2016) The Impact of Obesity on Gallstone Disease, Acute Pancreatitis, and Pancreatic Cancer. Gastroenterology Clinics of North America, 45, 625-637.
https://doi.org/10.1016/j.gtc.2016.07.010
|
[28]
|
Aune, D. and Vatten, L.J. (2016) Diabetes Mellitus and the Risk of Gallbladder Disease: A Systematic Review and Meta-Analysis of Prospective Studies. Journal of Diabetes and Its Com-plications, 30, 368-373.
https://doi.org/10.1016/j.jdiacomp.2015.11.012
|
[29]
|
Kim, H.S., Cho, S.K., Kim, C.S. and Park, J.S. (2019) Big Data and Analysis of Risk Factors for Gallbladder Disease in the Young Generation of Korea. PLOS ONE, 14, e0211480. https://doi.org/10.1371/journal.pone.0213950
|
[30]
|
Mulliri, A., Menahem, B., Alves, A., et al. Ursodeoxycholic Acid for the Prevention of Gallstones and Subsequent Cholecystectomy after Bariatric Surgery: a meta-Analysis of Ran-domized Controlled Trials. Journal of Gastroenterology, 57, 529-539. https://doi.org/10.1007/s00535-022-01886-4
|
[31]
|
Lim, R., Beekley, A., Johnson, D.C. and Davis, K.A. (2018) Early and Late Complications of Bariatric Operation. Trauma Surgery & Acute Care Open, 3, e000219. https://doi.org/10.1136/tsaco-2018-000219
|
[32]
|
Hasan, M.Y., Lomanto, D., Loh, L.L., So, J.B.Y. and Shabbir, A. (2017) Gallstone Disease after Laparoscopic Sleeve Gastrectomy in an Asian Population-What Proportion of Gallstones Actually Becomes Symptomatic? Obesity Surgery, 27, 2419-2423. https://doi.org/10.1007/s11695-017-2657-y
|
[33]
|
Wanjura, V., Sandblom, G., Österberg, J., et al. (2017) Cholecys-tectomy after Gastric Bypass—Incidence and Complications. Surgery for Obesity and Related Diseases, 13, 979-987. https://doi.org/10.1016/j.soard.2016.12.004
|
[34]
|
Thorarinsdottir, R., Palmason, V., Leifsson, B.G. and Gíslason, H. (2016) [Outcome of Gastric Bypass Surgery in Iceland 2001-2015]. Læknablaðið, 102, 426-432. (In Icelandic) https://doi.org/10.17992/lbl.2016.10.100
|
[35]
|
Sellers, Z.M., Thorson, C., Co, S., Schaberg, K.B. and Kerner, J.A. (2017) Feeling the Impact of Long-Term Total Parenteral Nutrition. Digestive Diseases and Sciences, 62, 3317-3320. https://doi.org/10.1007/s10620-017-4588-9
|
[36]
|
Tsunoda, K., Shirai, Y. and Hatakeyama, K. (2004) Prevalence of Cholesterol Gallstones Positively Correlates with Per Capita Daily Calorie Intake. Hepatogastroenterology, 51, 1271-1274.
|
[37]
|
Di Ciaula, A., Garruti, G., Frühbeck, G., et al. (2019) The Role of Diet in the Pathogenesis of Choles-terol Gallstones. Current Medicinal Chemistry, 26, 3620-3638. https://doi.org/10.2174/0929867324666170530080636
|
[38]
|
Su, C.-H., Lui, W.-Y. and P’eng, F.-K. (1992) Rela-tive Prevalence of Gallstone Diseases in Taiwan. A Nationwide Cooperative Study. Digestive Diseases and Sciences, 37, 764-768. https://doi.org/10.1007/BF01296436
|
[39]
|
Banim, P.J., Luben, R.N., Wareham, N.J., et al. (2010) Physi-cal Activity Reduces the Risk of Symptomatic Gallstones: A Prospective Cohort Study. European Journal of Gastroen-terology & Hepatology, 22, 983-988.
https://doi.org/10.1097/MEG.0b013e32833732c3
|
[40]
|
Ruhl, C.E. and Everhart, J.E. (2000) Association of Diabe-tes, Serum Insulin, and C-Peptide with Gallbladder Disease. Hepatology, 31, 299-303. https://doi.org/10.1002/hep.510310206
|
[41]
|
Al-Azzawi, H.H., Mathur, A., Lu, D., et al. (2007) Resistin-Like Molecule Alpha Reduces Gallbladder Optimal Tension. Journal of Gastrointestinal Surgery, 11, 95-100. https://doi.org/10.1007/s11605-006-0039-1
|
[42]
|
Bini, E.J. and McGready, J. (2005) Prevalence of Gallbladder Disease among Persons with Hepatitis C Virus Infection in the United States. Hepatology, 41, 1029-1036. https://doi.org/10.1002/hep.20647
|
[43]
|
Eguchi, Y., Mizuta, T., Ishibashi, E., et al. (2009) Hepatitis C Virus Infec-tion Enhances Insulin Resistance Induced by Visceral Fat Accumulation. Liver International, 29, 213-220. https://doi.org/10.1111/j.1478-3231.2008.01853.x
|
[44]
|
Acalovschi, M., Buzas, C., Radu, C. and Grigorescu, M. (2009) Hepatitis C Virus Infection is a Risk Factor for Gallstone Disease: A Prospective Hospital-Based Study of Pa-tients with Chronic Viral C Hepatitis. Journal of Viral Hepatitis, 16, 860-866. https://doi.org/10.1111/j.1365-2893.2009.01141.x
|
[45]
|
Stinton, L.M., Myers, R.P. and Shaffer, E.A. (2010) Epi-demiology of Gallstones. Gastroenterology Clinics of North America, 39, 157-169. https://doi.org/10.1016/j.gtc.2010.02.003
|
[46]
|
Talha, A., Abdelbaki, T., Farouk, A., et al. (2020) Cholelithiasis af-ter Bariatric Surgery, Incidence, and Prophylaxis: Randomized Controlled Trial. Surgical Endoscopy, 34, 5331-5337. https://doi.org/10.1007/s00464-019-07323-7
|
[47]
|
Möller, M., Gustafsson, U., Rasmussen, F., Persson, G. and Thorell, A. (2014) Natural Course vs Interventions to Clear Common Bile Duct Stones Data from the Swedish Registry for Gallstone Surgery and Endoscopic Retrograde Cholangiopancreatography (GallRiks). JAMA Surgery, 149, 1008-1013. https://doi.org/10.1001/jamasurg.2014.249
|
[48]
|
Shea, J.A., Berlin, J.A., Escarce, J.J., et al. (1994) Re-vised Estimates of Diagnostic Test Sensitivity and Specificity in Suspected Biliary Tract Disease. Archives of Internal Medicine, 154, 2573-2581.
https://doi.org/10.1001/archinte.154.22.2573
|
[49]
|
NICE (2014) Gallstone Disease: Diagnosis and Management of Cholelithiasis, Cholecystitis and Choledocholithiasis. National Institute for Health and Care Excellence (NICE), Lon-don.
|
[50]
|
Gutt, C., Jenssen, C., Barreiros, A.P., et al. (2018) [Updated S3-Guideline for Prophylaxis, Diagnosis and Treatment of Gallstones. German Society for Digestive and Metabolic Diseases (DGVS) and German Society for Sur-gery of the Alimentary Tract (DGAV) - AWMF Registry 021/008]. Zeitschrift für Gastroenterologie, 56, 912-966. (In German)
|
[51]
|
Ahmed, M. and Diggory, R. (2011) The Correlation between Ultrasonography and Histology in the Search for Gallstones. The Annals of the Royal College of Surgeons of England, 93, 81-83.
https://doi.org/10.1308/003588411X12851639107070
|
[52]
|
Altun, E., Semelka, R.C., Elias Jr., J., et al. (2007) Acute Cholecystitis: MR Findings and Differentiation from Chronic Cholecystitis. Radiology, 244, 174-183. https://doi.org/10.1148/radiol.2441060920
|
[53]
|
Tonolini, M., Ravelli, A., Villa, C. and Bianco, R. (2012) Urgent MRI with MR Cholangiopancreatography (MRCP) of Acute Cholecystitis and Related Complications: Diagnostic Role and Spectrum of Imaging Findings. Emergency Radiology, 19, 341-348. https://doi.org/10.1007/s10140-012-1038-z
|
[54]
|
Soyer, P., Hoeffel, C., Dohan, A., et al. (2013) Acute Cholecysti-tis: Quantitative and Qualitative Evaluation with 64-Section Helical CT. Acta Radiologica, 54, 477-486. https://doi.org/10.1177/0284185113475798
|
[55]
|
Yokoe, M., Takada, T., Strasberg, S.M., et al. (2012) New Diag-nostic Criteria and Severity Assessment of Acute Cholecystitis in Revised Tokyo Guidelines. Journal of Hepa-to-Biliary-Pancreatic Sciences, 19, 578-585.
|
[56]
|
Pinto, A., Reginelli, A., Cagini, L., et al. (2013) Accuracy of Ultra-sonography in the Diagnosis of Acute Calculous Cholecystitis: Review of the Literature. Critical Ultrasound Journal, 5, Article No. S11.
https://doi.org/10.1186/2036-7902-5-S1-S11
|
[57]
|
Gutt, C.N., Encke, J., et al. (2013) Acute Cholecystitis: Early versus Delayed Cholecystectomy, A Multicenter Randomized Trial (ACDC Study, NCT00447304). Annals of Surgery, 258, 385-393.
https://doi.org/10.1097/SLA.0b013e3182a1599b
|
[58]
|
(2010) ASGE Standards of Practice Committee: The Role of Endoscopy in the Evaluation of Suspected Choledocholithiasis. Gastrointestinal Endoscopy, 71, 1-9.
|
[59]
|
Meeralam, Y., Al-Shammari, K. and Yaghoobi, M. (2017) Diagnostic Accuracy of EUS Compared with MRCP in Detecting Cho-ledocholithiasis: A Meta-Analysis of Diagnostic Test Accuracy in Head-to-Head Studies. Gastrointestinal Endoscopy, 86, 986-993. https://doi.org/10.1016/j.gie.2017.06.009
|
[60]
|
Verma, D., Kapadia, A., Eisen, G.M. and Adler, D.G. (2006) EUS vs MRCP for Detection of Choledocholithiasis. Gastrointestinal Endoscopy, 64, 248-254. https://doi.org/10.1016/j.gie.2005.12.038
|
[61]
|
Henderson, S.O., Swadron, S. and Newton, E. (2002) Comparison of Intravenous Ketorolac and Meperidine in the Treatment of Biliary Colic. Journal of Emergency Medicine, 23, 237-241.
https://doi.org/10.1016/S0736-4679(02)00524-3
|
[62]
|
Kumar, A., Deed, J.S., Bhasin, B., Kumar, A. and Thomas, S. (2004) Comparison of the Effect of Diclofenac with Hyoscine-N-Butylbromide in the Symptomatic Treatment of Acute Biliary Colic. ANZ Journal of Surgery, 74, 573-576.
https://doi.org/10.1111/j.1445-2197.2004.03058.x
|
[63]
|
Jüngst, C., Sreejayan, N., Zündt, B., et al. (2008) Ursode-oxycholic Acid Reduces Lipid Peroxidation and Mucin Secretagogue Activity in Gallbladder Bile of Patients with Cho-lesterol Gallstones. European Journal of Clinical Investigation, 38, 634-639. https://doi.org/10.1111/j.1365-2362.2008.01995.x
|
[64]
|
Coupaye, M., Calabrese, D., Sami, O., Msika, S. and Le-doux, S. (2017) Evaluation of Incidence of Cholelithiasis after Bariatric Surgery in Subjects Treated or Not Treated with Ursodeoxycholic Acid. Surgery for Obesity and Related Diseases, 13, 681-685. https://doi.org/10.1016/j.soard.2016.11.022
|
[65]
|
罗玲玲, 于江, 魏会强, 等. 熊去氧胆酸的合成研究进展[J]. 合成化学, 2021, 29(11): 986-996.
|
[66]
|
Pulkkinen, J., Eskelinen, M., Kiviniemi, V., et al. (2014) Effect of Statin Use on Outcome of Symptomatic Cholelithiasis: A Case-Control Study. BMC Gastroenterology, 14, Article No. 119. https://doi.org/10.1186/1471-230X-14-119
|
[67]
|
Erichsen, R., Frøslev, T., Lash, T.L., et al. (2011) Long-Term Statin Use and the Risk of Gallstone Disease: A Population-Based Case-Control Study. American Journal of Epidemiol-ogy, 173, 162-170. https://doi.org/10.1093/aje/kwq361
|
[68]
|
Bodmer, M., Brauchli, Y.B., Krähenbühl, S., Jick, S.S. and Meier, C.R. (2009) Statin Use and Risk of Gallstone Disease Followed by Cholecystectomy. JAMA, 302, 2001-2007. https://doi.org/10.1001/jama.2009.1601
|
[69]
|
Ahmed, M.H., Hamad, M.A., Routh, C. and Connolly, V. (2011) Statins as Potential Treatment for Cholesterol Gallstones: An Attempt to Understand the Underlying Mechanism of Ac-tions. Expert Opinion on Pharmacotherapy, 12, 2673-2681. https://doi.org/10.1517/14656566.2011.629995
|
[70]
|
徐敬昌, 叶辉, 王大松. 药物防治胆囊结石研究进展[J]. 临床肝胆病杂志, 2018, 34(11): 2453-2457.
|
[71]
|
Yu, X.-H., Qian, K., Jiang, N., et al. (2014) ABCG5/ABCG8 in Cholesterol Excretion and Atherosclerosis. Clinica Chimica Acta, 428, 82-88. https://doi.org/10.1016/j.cca.2013.11.010
|
[72]
|
Cariello, M., Piccinin, E., Garcia-Irigoyen, O., Sabbà, C. and Moschetta, A. (2018) Nuclear Receptor FXR, Bile Acids and Liver Damage: Introducing the Progressive Familial Intrahepatic Cholestasis with FXR Mutations. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 1864, 1308-1318. https://doi.org/10.1016/j.bbadis.2017.09.019
|
[73]
|
de Bari, O., Neuschwander-Tetri, B.A., Liu, M., Portincasa, P. and Wang, D.Q.-H. (2012) Ezetimibe: Its Novel Effects on the Prevention and the Treatment of Cho-lesterol Gallstones and Nonalcoholic Fatty Liver Disease. Journal of Lipids, 2012, Article ID: 302847. https://doi.org/10.1155/2012/302847
|
[74]
|
Wang, D.Q.-H., Zhang, L. and Wang, H.H. (2005) High Cholesterol Absorption Efficiency and Rapid Biliary Secretion of Chylomicron Remnant Cholesterol Enhance Cholelithogenesis in Gallstone-Susceptible Mice. Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids, 1733, 90-99.
https://doi.org/10.1016/j.bbalip.2004.12.005
|
[75]
|
Lauridsen, B.K., Stender, S., Frikke-Schmidt, R., Nordestgaard, B.G. and Tybjærg-Hansen, A. (2015) Genetic Variation in the Cholesterol Transporter NPC1L1, Ischaemic Vascular Disease, and Gallstone Disease. European Heart Journal, 36, 1601-1608. https://doi.org/10.1093/eurheartj/ehv108
|
[76]
|
冯矗, 罗浩, 万柳华, 等. 胆囊结石药物治疗现状[J]. 临床军医杂志, 2022, 50(5): 544-546.
|
[77]
|
冯健, 崔乃强. 中西医结合治疗胆石病的现状与展望[J]. 临床肝胆病杂志, 2018, 34(4): 704-709.
|
[78]
|
Lammert, F., Gurusamy, K., Ko, C.W., et al. (2016) Gallstones. Nature Reviews Disease Primers, 2, Article No. 16024.
https://doi.org/10.1038/nrdp.2016.24
|
[79]
|
李丽梅. 快速康复外科护理对腹腔镜胆囊切除患者康复效果的影响[J]. 医疗装备, 2018, 31(1): 196-197.
|
[80]
|
冯宪光, 张增臻, 梁荔, 等. 腹腔镜胆囊造瘘术联合术后胆道镜取石在高龄急危重症胆囊结石患者的临床观察[J]. 中国现代普通外科进展, 2018, 21(2): 124-126.
|
[81]
|
张宝善. 微创外科内镜保胆的新思维[J]. 微创医学, 2010, 5(3): 193-196.
|
[82]
|
陈光彬, 刘丹峰, 刘昌阔(综述), 孙礼侠(审校). 腹腔镜联合胆道镜微创保胆取石术的研究进展[J]. 中国微创外科杂志, 2015(12): 1133-1135, 1140.
|
[83]
|
内镜微创保胆手术指南(2011版)中国医师协会内镜医师分会微创保胆委员会[J]. 中国内镜杂志, 2013, 19(2): I0049-I0050.
|
[84]
|
Atallah, S., Martin-Perez, B., Keller, D., Burke, J. and Hunter, L. (2015) Natural-Orifice Translu-minal Endoscopic Surgery. British Journal of Surgery, 102, e73-e92. https://doi.org/10.1002/bjs.9710
|
[85]
|
黄成宽. 胆结石手术治疗的临床研究进展[J]. 临床医药文献电子杂志, 2018, 5(76): 197-198.
|
[86]
|
肖坤, 陈倩, 谭庆丰. 胆囊结石合并胆总管结石的治疗进展[J]. 世界最新医学信息文摘, 2019, 19(35): 127-128.
|
[87]
|
王羊, 张成, 冯金鸽, 赵宝国. 十二指肠镜联合微创手术治疗胆囊结石合并胆总管巨大结石的临床研究[J]. 腹腔镜外科杂志, 2018, 23(12): 901-906.
|